Both in Biotechnology
Humacyte vs Armata Pharmaceuticals
Over the past year HUMA returned −72.3% and ARMP returned −36.0%; their daily moves had a correlation of 0.14.
HUMA −72.3% ARMP −36.0%Growth of $1, one year, split-adjusted
| Metric | HUMA | ARMP |
|---|---|---|
| Price | $0.4405 | $3.09 |
| Market cap | $122.4M | $114.9M |
| Today | +10.65% | +8.42% |
| 1 month | −11.9% | −15.6% |
| 6 months | −51.2% | −67.0% |
| Year to date | −54.1% | −50.8% |
| 1 year | −73.6% | −37.1% |
| Revenue growth (YoY) | +34.9% | +15.7% |
| Gross margin | −203.2% | 100.0% |
| Net margin | −9064.5% | 2953.8% |
| P/E (TTM) | — | — |
| Price / sales | 57.7× | 20.7× |
| Net cash | $13.7M | -$259.6M |
| Dividend yield | — | — |
| Volatility (60d) | 108.0% | 115.8% |
| Short % of float | 11.9% | 4.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).